Baicalein Treatment Promotes Osteoblast Proliferation and Osteogenic Differentiation through Activation of Immediate Early Response 3
10.17135/jdhs.2019.19.4.254
- Author:
Sang Im LEE
1
Author Information
1. Department of Dental Hygiene, College of Health Sciences, Dankook University, Cheonan 31116, Korea. hanjumuck@dankook.ac.kr
- Publication Type:Original Article
- Keywords:
Baicalein;
Immediate early response 3 protein;
Osteogenesis;
Periodontal disease
- MeSH:
Anti-Bacterial Agents;
Anti-Inflammatory Agents;
Biological Products;
Blotting, Western;
Calculi;
Cell Proliferation;
Cytokines;
Dental Plaque;
Down-Regulation;
Humans;
Inflammation;
Interleukins;
JNK Mitogen-Activated Protein Kinases;
MAP Kinase Signaling System;
Osteoblasts;
Osteogenesis;
Periodontal Diseases;
Periodontal Ligament;
Phosphorylation;
Phosphotransferases;
Real-Time Polymerase Chain Reaction;
Regeneration;
RNA, Messenger;
Signal Transduction;
Tooth Loss;
Transcription Factors;
Tumor Necrosis Factor-alpha;
Up-Regulation
- From:
Journal of Dental Hygiene Science
2019;19(4):254-260
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: The primary aims of periodontal disease treatment is to remove dental plaque and calculus, the main causes of tooth loss, and restore periodontal tissue destroyed by inflammation. Periodontal disease treatment should also help maintain the alveolar bone, alleviate inflammation, and promote periodontal ligament cell proliferation, which is essential for tissue regeneration. Conventional antibiotics and anti-inflammatories have adverse side effects, especially during long-term use, so there is a need for adjunct treatment agents derived from natural products. The purpose of this study was to investigate whether the herbal flavone baicalein has the osteogenic activity under inflammatory conditions, and assess the involvement of osteoblast immediate early response 3 (IER3) expression.METHODS: Human osteoblastic MG-63 cells were cultured with the pro-inflammatory cytokines tumor necrosis factor α and interleukin 1β in the presence and absence of baicalein. Proliferation was assessed using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay, and expression of IER3 mRNA was assessed using real-time polymerase chain reaction. The expression of IER3 protein levels and activation of associated signal transduction pathways were assessed using western blotting.RESULTS: Baicalein increased IER3 mRNA and protein expression synergistically. In addition, baicalein reversed the suppression of cell proliferation, and the downregulation of osteogenic transcription factor runt-related transcription factor 2 and osterix induced by pro-inflammatory cytokines. Baicalein also upregulated the phosphorylation of c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK 1/2). The upregulation of IER3 by pro-inflammatory cytokines was blocked by pretreatment with inhibitors of AKT, p38, JNK, and ERK 1/2.CONCLUSION: Baicalein mitigates the deleterious responses of osteoblasts to pro-inflammatory cytokines. Further, IER3 enhanced the effect of baicalein via activation of AKT, p38, JNK, and ERK pathways.
